tradingkey.logo
tradingkey.logo
Search

Sinovac Biotech Ltd

SVA
Add to Watchlist
0.0000.00%
Close 12-22 16:00ETQuotes delayed by 15 min
--Market Cap
--P/E TTM
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

0.00%

1 Month

0.00%

6 Months

0.00%

Year to Date

0.00%

1 Year

0.00%

Key Figures
--Open
0.000High
0.00Volume
--P/E TTM
--P/E Dynamic
--Dividend TTM
--Turnover Ratio
--Prev. Close
0.000Low
0.00Turnover
--P/E Static
--P/B
--Div Yield TTM
--ROA
--52wk High
--Volume Ratio
--Net Profit
--Shares
--EPS TTM
--Beta
--ROE
--52wk Low
--Amplitude
--Gross Margin
--Market Cap
--Reward/Risk
--Risk Rate

Sinovac Biotech Ltd News

More news coming soon, stay tuned...

Indicators

Indicators
Sell(0)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.000
Neutral
RSI(14)
0.000
Oversold
STOCH(KDJ)(9,3,3)
0.000
Oversold
ATR(14)
0.000
Neutral
CCI(14)
0.000
Neutral
Williams %R
0.000
Overbought
TRIX(12,20)
0.000
Neutral
StochRSI(14)
0.000
Oversold
Moving Average
Sell(0)
Neutral(6)
Buy(0)
Indicators
Value
Direction
MA5
0.000
Neutral
MA10
0.000
Neutral
MA20
0.000
Neutral
MA50
0.000
Neutral
MA100
0.000
Neutral
MA200
0.000
Neutral

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Sinovac Biotech Ltd Info

Sinovac Biotech Ltd (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, hand foot and mouth disease (HFMD), seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine.
Ticker SymbolSVA
CompanySinovac Biotech Ltd
CEOYin (Weidong)
Websitehttp://www.sinovac.com/

Shareholders

Shareholders
Shareholders
Proportion
1Globe Capital, L.L.C.
20.84%
SAIF Advisors Limited
17.95%
Yin (Weidong)
10.59%
CDH Utopia Ltd
9.99%
Vivo Capital, LLC
9.83%
Other
30.81%

FAQs

What is the symbol of Sinovac Biotech Ltd?

The ticker symbol of Sinovac Biotech Ltd is SVA.

What is the Earnings Per Share (EPS TTM) of Sinovac Biotech Ltd (SVA)?

The Earnings Per Share (EPS TTM) of Sinovac Biotech Ltd (SVA) is -0.83.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.